Free Trial

Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

Thermo Fisher Scientific logo
$464.64 -9.82 (-2.07%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$464.25 -0.39 (-0.08%)
As of 05/8/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Thermo Fisher Scientific Stock (NYSE:TMO)

Advanced

Key Stats

Today's Range
$456.36
$473.49
50-Day Range
$463.99
$531.69
52-Week Range
$385.46
$643.99
Volume
3.89 million shs
Average Volume
2.13 million shs
Market Capitalization
$172.67 billion
P/E Ratio
25.54
Dividend Yield
0.40%
Price Target
$619.65
Consensus Rating
Buy

Company Overview

Thermo Fisher Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

TMO MarketRank™: 

Thermo Fisher Scientific scored higher than 95% of companies evaluated by MarketBeat, and ranked 16th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Thermo Fisher Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 19 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Thermo Fisher Scientific has a consensus price target of $619.65, representing about 33.4% upside from its current price of $464.64.

  • Amount of Analyst Coverage

    Thermo Fisher Scientific has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Thermo Fisher Scientific's stock forecast and price target.
  • Earnings Growth

    Earnings for Thermo Fisher Scientific are expected to grow by 9.77% in the coming year, from $24.86 to $27.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Thermo Fisher Scientific is 25.54, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Thermo Fisher Scientific is 25.54, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.96.

  • Price to Earnings Growth Ratio

    Thermo Fisher Scientific has a PEG Ratio of 2.06. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Thermo Fisher Scientific has a P/B Ratio of 3.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Thermo Fisher Scientific's valuation and earnings.
  • Short Interest

    There is no current short interest data available for TMO.
  • Dividend Yield

    Thermo Fisher Scientific has a dividend yield of 0.40%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Thermo Fisher Scientific has been increasing its dividend for 8 years.

  • Dividend Coverage

    The dividend payout ratio of Thermo Fisher Scientific is 10.34%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.89% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.

  • Read more about Thermo Fisher Scientific's dividend.
  • News Sentiment

    Thermo Fisher Scientific has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 39 news articles for Thermo Fisher Scientific this week, compared to 13 articles on an average week.
  • Search Interest

    44 people have searched for TMO on MarketBeat in the last 30 days. This is an increase of 175% compared to the previous 30 days.
  • MarketBeat Follows

    Only 13 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -19% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,963,544.00 in company stock.

  • Percentage Held by Insiders

    0.33% of the stock of Thermo Fisher Scientific is held by insiders.

  • Percentage Held by Institutions

    89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Thermo Fisher Scientific's insider trading history.
Receive TMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Stock News Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
Thermo Fisher Scientific Inc.
NET, DDOG, PANW, TMO, and T logos with rising candlestick chart, highlighting momentum stocks beating their sectors.
The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down (TMO)
These five stocks are outperforming their beaten-down sectors on strong fundamentals, not hype, making them momentum plays worth watching now.
See More Headlines

TMO Stock Analysis - Frequently Asked Questions

Thermo Fisher Scientific's stock was trading at $579.42 on January 1st, 2026. Since then, TMO stock has decreased by 19.8% and is now trading at $464.6370.

Thermo Fisher Scientific Inc. (NYSE:TMO) released its quarterly earnings results on Thursday, April, 23rd. The medical research company reported $5.44 earnings per share for the quarter, beating analysts' consensus estimates of $5.25 by $0.19. The company's revenue was up 6.2% compared to the same quarter last year.
Read the conference call transcript
.

Thermo Fisher Scientific's Board of Directors initiated a stock buyback plan on Thursday, November 6th 2025, which permits the company to repurchase $5,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 2.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's management believes its shares are undervalued.

Thermo Fisher Scientific subsidiaries include these companies: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more.

Top institutional shareholders of Thermo Fisher Scientific include Bank of New York Mellon Corp (1.01%), Pictet Asset Management Holding SA (0.55%), Dimensional Fund Advisors LP (0.45%) and Swedbank AB (0.40%). Insiders that own company stock include Marc N Casper, Michel Lagarde, Stephen Williamson, Gianluca Pettiti, Michael D Shafer, Frederick M Lowery, Lisa P Britt, Michael A Boxer, Joseph R Holmes and Debora L Spar.
View institutional ownership trends
.

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include BlackRock (BLK), Broadcom (AVGO), UnitedHealth Group (UNH), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW) and NVIDIA (NVDA).

Company Calendar

Record date for 4/15 Dividend
3/13/2026
Ex-Dividend for 4/15 Dividend
3/13/2026
Dividend Payable
4/15/2026
Last Earnings
4/23/2026
Today
5/09/2026
Investor Day 2026
5/20/2026
AGM 2026
5/20/2026
Next Earnings (Estimated)
7/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:TMO
CIK
97745
Employees
125,000
Year Founded
1956

Price Target and Rating

High Price Target
$750.00
Low Price Target
$510.00
Potential Upside/Downside
+33.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
23 Analysts

Profitability

EPS (Trailing Twelve Months)
$18.19
Trailing P/E Ratio
25.54
Forward P/E Ratio
18.69
P/E Growth
2.06
Net Income
$6.70 billion
Net Margins
15.15%
Pretax Margin
16.42%
Return on Equity
16.86%
Return on Assets
8.15%

Debt

Debt-to-Equity Ratio
0.77
Current Ratio
1.53
Quick Ratio
1.15

Sales & Book Value

Annual Sales
$44.56 billion
Price / Sales
3.88
Cash Flow
$30.37 per share
Price / Cash Flow
15.30
Book Value
$139.77 per share
Price / Book
3.32

Miscellaneous

Outstanding Shares
371,620,000
Free Float
370,395,000
Market Cap
$172.67 billion
Optionable
Optionable
Beta
0.88

Social Links

Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NYSE:TMO) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners